Metastatic cancer: 72% reduced risk of tumor spread with exercise
Another reason to sweat
Another reason to sweat
Cynthia Qi, Health Economics Outcomes Researcher at Argenx, discusses myasthenia gravis and real-life data.
Björn Mellgård, M.D., Ph.D., Vice President, Global Program Lead, Rare Genetics and Hematology, Takeda, breaks down Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare, genetic disorder that affects the nervous and musculoskeletal systems of young patients.
Journal of the Endocrine Society (JES), an open access publication, provides rapid peer review and publication of research and other contributions that advance basic science,…
Websites focused on inhaler technique frequently overlook important preparation steps and device care/maintenance, according to results published in Respiratory Medicine.These findings emphasize the importance of…
Penumbra announced the FDA clearance and launch of its next-generation computer-assisted vacuum thrombectomy system to remove venous thrombus and treat pulmonary emboli.The thrombectomy system (Lightning…
Data from 2 NETTER trials support lutetium Lu 177 dotatate’s approval in somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
This Viewpoint examines whether selective androgen receptor modulators have the potential to be transformative drugs or whether they herald the next drug epidemic.
We invite you to join us for an enlightening webinar, “Unlocking the Future of Healthcare Quality – Leveraging the Oxford Professional Practice Handbook of Quality…
Cochrane is using Slack, an online collaboration and chat platform, to encourage communication between members of our core community.